Literature DB >> 10547597

Expression of p16 and lack of pRB in primary small cell lung cancer.

J Yuan1, J Knorr, M Altmannsberger, G Goeckenjan, A Ahr, A Scharl, K Strebhardt.   

Abstract

The retinoblastoma protein (pRB), p16, and cyclin D1 are major components of the RB pathway, which controls the G1 checkpoint of the cell cycle. Proper regulation of this pathway is crucial for normal cell proliferation. Abnormal forms of these proteins have been found in various types of malignant tumours. In the present report, immunohistochemical techniques were applied to study the expression of pRB, p16, and cyclin D1 in 161 samples of primary small cell lung cancer (SCLC) and 20 samples of non-small cell lung cancer (NSCLC). While pRB and cyclin D1 staining was negative in 161 specimens of SCLC, expression of p16 was observed in 153 samples. In contrast to SCLC, 16 out of 20 NSCLC cases exhibited pRB expression and 15 showed cyclin D1 expression, but only very weak p16 staining was found in five samples. These observations could provide additional criteria for the distinction between SCLC and NSCLC. Furthermore, these findings, based on primary tissues, implicate different mechanisms in the tumourigenesis of SCLC and NSCLC. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10547597     DOI: 10.1002/(SICI)1096-9896(199911)189:3<358::AID-PATH452>3.0.CO;2-1

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  28 in total

1.  p16 overexpression in high-grade neuroendocrine carcinomas of the head and neck: potential diagnostic pitfall with HPV-related carcinomas.

Authors:  Llucia Alos; Sofia Hakim; Ana-Belen Larque; Jorge de la Oliva; Leonardo Rodriguez-Carunchio; Miguel Caballero; Alfons Nadal; Carles Marti; Nuria Guimera; Maria-Teresa Fernandez-Figueras; Wim Quint; Jaume Ordi
Journal:  Virchows Arch       Date:  2016-07-08       Impact factor: 4.064

2.  Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.

Authors:  Ana Amélia de Souza; Albina Altemani; Fabricio Passador-Santos; Cecilia Pedroso Turssi; Ney Soares de Araujo; Vera Cavalcanti de Araújo; Andresa Borges Soares
Journal:  Virchows Arch       Date:  2015-07-09       Impact factor: 4.064

3.  Recalcitrant small cell lung cancer: the argument for optimism.

Authors:  Karen G Zeman; Christina E Brzezniak; Corey A Carter
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

4.  Cell cycle related proteins as prognostic parameters in radically resected non-small cell lung cancer.

Authors:  V Esposito; A Baldi; A De Luca; G Tonini; B Vincenzi; D Santini; P Persichetti; A Mancini; G Citro; F Baldi; A M Groeger; M Caputi
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

5.  Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma.

Authors:  Hsueh-Li Tan; Akshay Sood; Hameed A Rahimi; Wenle Wang; Nilesh Gupta; Jessica Hicks; Stacy Mosier; Christopher D Gocke; Jonathan I Epstein; George J Netto; Wennuan Liu; William B Isaacs; Angelo M De Marzo; Tamara L Lotan
Journal:  Clin Cancer Res       Date:  2013-12-09       Impact factor: 12.531

Review 6.  Tailoring to RB: tumour suppressor status and therapeutic response.

Authors:  Erik S Knudsen; Karen E Knudsen
Journal:  Nat Rev Cancer       Date:  2008-09       Impact factor: 60.716

7.  Large Cell Neuroendocrine Carcinoma of the Head and Neck: A Clinicopathologic Series of 10 Cases With an Emphasis on HPV Status.

Authors:  Elizabeth D Thompson; Edward B Stelow; Stacey E Mills; William H Westra; Justin A Bishop
Journal:  Am J Surg Pathol       Date:  2016-04       Impact factor: 6.394

Review 8.  P16INK4A as a surrogate biomarker for human papillomavirus-associated oropharyngeal carcinoma: consideration of some aspects.

Authors:  Hongzhi Wang; Rui Sun; Hui Lin; Wei-Han Hu
Journal:  Cancer Sci       Date:  2013-11-08       Impact factor: 6.716

9.  Alterations of gene expression of RB pathway in Opisthorchis viverrini infection-induced cholangiocarcinoma.

Authors:  Thidarut Boonmars; Zhiliang Wu; Sirintip Boonjaruspinyo; Somchai Pinlaor; Isao Nagano; Yuzo Takahashi; Butsara Kaewsamut; Puangrat Yongvanit
Journal:  Parasitol Res       Date:  2009-07-07       Impact factor: 2.289

10.  Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas.

Authors:  Harrison Tsai; Carlos L Morais; Mohammed Alshalalfa; Hsueh-Li Tan; Zaid Haddad; Jessica Hicks; Nilesh Gupta; Jonathan I Epstein; George J Netto; William B Isaacs; Jun Luo; Rohit Mehra; Robert L Vessella; R Jeffrey Karnes; Edward M Schaeffer; Elai Davicioni; Angelo M De Marzo; Tamara L Lotan
Journal:  Clin Cancer Res       Date:  2015-08-05       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.